Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest

Stroke

Volumn 28, Issue 11, 1997, Pages 2230-2237

  Crumrine, R Christian ^a   Bergstrand, Kristine ^a   Cooper, Amy T ^a   Faison, Walter L ^a   Cooper, Barrett R ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Anticonvulsant; Antidepressant agents; Cerebral ischemia; Global neuroprotection; Heart arrest; Rats; Sodium channels

Indexed keywords

LAMOTRIGINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HEART ARREST; HIPPOCAMPUS; NEUROPROTECTION; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT;

EID: 0342618284     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.11.2230     Document Type: Article

References (46)

1. Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987;7:357-368.
2. Rothman SM, Thurston JH, Hauhart RE. Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience. 1987;22:471-480.
3. McDonald JW, Roeser NF, Silverstein FS, Johnston MV. Quantatine assessment of neuroprotection against NMDA-induced brain injury. Exp Neurol. 1989;106:289-296.
4. Fujisawa H, Dawson D, Browne SE, Mackay KB, Bullock R, McCulloch J. Pharmacological modification of glutamate neurotoxicity in vivo. Brain Res. 1993;629:73-78.
5. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990;13: 171-182.
6. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic - ischemic brain damage. Ann Neurol. 1986;19:105-111.
7. McCulloch J. Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. Br J Clin Pharmacol. 1992;34:106-114.
8. Swan JH, Meldrum BS. Protection by NMDA antagonists against selective cell loss following transient ischaemia. J Cereb Blood Flow Metab. 1990;10:343-351.
9. Ito U, Spatz M, Walker JT, Klatzo I. Experimental cerebral ischemia in Mongolian gerbils. Acta Neuropathol (Berl). 1975;32:209-223.
10. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982;239:57-69.
11. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol. 1982;11:491-498.
12. Crumrine RC, LaManna JC. Regional cerebral metabolites, blood flow, plasma volume, and mean transit time in total cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1991;11:272-282.
13. Petito CK, Feldmann E, Pulsinelli WA, Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology. 1987;37:1281-1286.
14. Scatton B, Frost J, George P, Carter C, Benavides J. Present developments in NMDA receptor antagonists against cerebral ischaemia. Current Patents Ltd. 1994;ISSN 0926-2594:523-545.
15. Buchan A, Li H, Pulsinelli WA. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J Neurosci. 1991; 11:1049-1056.
16. Buchan A, Pulsinelli WA. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci. 1990;10: 311-316.
17. Michenfelder JD, Lanier WL, Scheithauer BW, Perkins WJ, Shearman GT, Milde JH. Evaluation of the glutamate antagonist dizocilipine maleate (MK-801) on neurologic outcome in a canine model of complete cerebral ischemia: correlation with hippocampal histopathology. Brain Res. 1989;481:228-234.
18. Lanier WL, Perkins WJ, Karlsson BR, Milde JH, Scheithauer BW, Shearman GT, Michenfelder JD. The effects of dizocilpine maleate (MK-801), an antagonist of the N-methyl-D-aspartate receptor, on neurologic recovery and histopathology following complete cerebral ischemia in primates. J Cereb Blood Flow Metab. 1990;10: 252-261.
19. Gill R, Woodruff GN. The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia. Eur J Pharmacol. 1990;176:143-149.
20. Nellgard B, Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J Cereb Blood Flow Metab. 1992;12:2-11.
21. Sharp FR, Jasper P, Hall J, Noble L, Sagar SM. MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neurol. 1991;30: 801-809.
22. Leach MJ, Marden CM, Miller AA. Pharmacological studies on LTG, a novel potential antiepileptic drug. II: neurochemical studies on the mechanism of action. Epilepsia. 1986;27:490-497.
23. Lees G, Leach MJ. Studies on the mechanism of action of the novel anticonvulsant LTG (Lamictal) using primary neurological cultures from rat cortex. Brain Res. 1993;612:190-199.
24. Lang DG, Wang CM, Cooper BR. LTG, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther. 1993;266: 829-835.
25. Cheung H, Kamp D, Harris E. An in vitro investigation of the action of LTG on neuronal voltage-activated sodium channels. Epilepsy Res. 1992;13:107-112.
26. Meldrum BS, Swan JH, Leach MJ, Millan MH, Gwinn R, Kadota K, Graham SH, Chen J, Simon RP. Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87. Brain Res. 1992;593:1-6.
27. Graham SH, Chen J, Sharp FR, Simon RP. Limiting ischemic injury by inhibition of excitatory amino acid release. J Cereb Blood Flow Metab. 1993;13:88-97.
28. Graham SH, Chen J, Lan J, Leach MJ, Simon RP. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels. BW619C89, in rat middle cerebral artery occlusion. J Pharmacol Exp Ther. 1994;269:854-859.
29. Leach MJ, Swan JH, Eisenthal D, Dopson M, Nobbs M. BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke. 1993;24:1063-1067.
30. Smith SE, Meldrum BS. Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke. 1995;26:117-121.
31. Lekieffre D, Meldrum BS. The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats: a microdialysis and histological study. Neuroscience. 1993;56:93-99.
32. Rataud J, Debarnot F, Mary V, Pratt J, Stutzmann J-M. Comparative study of voltage-sensitive sodium channel blockers in focal ischemia and electric convulsions in rodents. Neurosci Lett. 1994; 172:19-23.
33. Wiard RP, Dickerson MC, Beek O, Norton R, Cooper BR. Neuroprotective properties of the novel antiepileptic LTG in a gerbil model of global cerebral ischemia. Stroke. 1995;26:466-472.
34. Shuaib A, Mahmood RH, Wishart T, Kanthan R, Murabit MA, Ijaz S, Miyashita H, Hewlett W. Neuroprotective effects of lamotrigine in global ischemia in gerbils: a histological, in vivo microdialysis and behavioral study. Brain Res. 1995;702:199-206.
35. Bacher A, Zornow MH. Lamotrigine inhibits extracellular glutamate accumulation during transient global cerebral ischemia in rabbits. Anesthesiology. 1997;86:459-463.
36. Lowry OH, Passonneau JV. A Flexible System of Enzyme Analysis. New York, NY: Academic Press Inc; 1972.
37. LaManna JC, Romeo SA, Crumrine RC, McCracken KA. Decreased blood volume with hypoperfusion during recovery from total cerebral ischaemia in dogs. Neurol Res. 1985;7:161-165.
38. Michenfelder JD, Milde JH. Postischemic canine cerebral blood flow appears to be determined by cerebral metabolic needs. J Cereb Blood Flow Metab. 1990;10:71-76.
39. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;43:1369-1374.
40. Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J Neurochem. 1988;51:1455-1464.
41. Hagberg H, Lehmann A, Sandberg M, Nystrom B, Jacobson I, Hamberger A. Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J Cereb Blood Flow Metab. 1985;5:413-419.
42. Busto R, Dietrich WD, Globus MY-T, Valdes I, Scheinberg P, Ginsberg MD. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab. 1987;7:729-738.
43. Leach MJ, Baxter MG, Critchley MA. Neurochemical and behavioral aspects of LTG. Epilepsia. 1991;32(suppl 2):S4-S8.
44. Iijima T, Mies G, Hossmann KA. Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: effect on volume of ischemic injury. J Cereb Blood Flow Metab. 1992;12:727-733.
45. Schwartz PH, Wasterlain CG. Cardiac arrest and resuscitation alters the pharmacokinetics of MK-801 in the rat. Res Comm Chem Pathol Pharmacol. 1991;73:181-195.
46. Faught E, Leroy RF, Messenheimer JA, Matsuo F, Bergen D, Dren AT, Keaney PA. Clinical experience with LTG (Lamictal) monotherapy for partial seizures in adult outpatients. Presented at the Annual Meeting of the American Epilepsy Society. Dec 4-10 Seattle, Wash, 1992. Abstract.